Trial Profile
Long-Term Specified Drug Use-Results Survey in Patients With Pre-dialysis Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Astellas Pharma
- 24 Jan 2019 Status changed from active, no longer recruiting to completed.
- 21 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Sep 2016 Status changed from not yet recruiting to recruiting.